Searching News Database: XTR
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 9 Oct 2024
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
HSMN NewsFeed - 21 Jun 2024
FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review
FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review
HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
HSMN NewsFeed - 2 May 2024
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
HSMN NewsFeed - 25 Apr 2024
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
HSMN NewsFeed - 7 Feb 2024
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
HSMN NewsFeed - 20 Dec 2023
FeelTect secures €1.5 million investment for connected wound treatment technology
FeelTect secures €1.5 million investment for connected wound treatment technology
HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
HSMN NewsFeed - 4 Oct 2023
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
HSMN NewsFeed - 18 Sep 2023
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
HSMN NewsFeed - 21 Aug 2023
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
HSMN NewsFeed - 14 Aug 2023
HAPPE Spine Announces First Clinical Use of the INTEGRATE(R)-C Interbody Fusion System
HAPPE Spine Announces First Clinical Use of the INTEGRATE(R)-C Interbody Fusion System
HSMN NewsFeed - 15 Jun 2023
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries
HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
HSMN NewsFeed - 28 Dec 2022
Inspira(TM) Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
Inspira(TM) Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
HSMN NewsFeed - 20 Sep 2022
Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement
Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement
HSMN NewsFeed - 22 Aug 2022
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
HSMN NewsFeed - 20 Apr 2022
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
HSMN NewsFeed - 14 Mar 2022
Shoulder Innovations Announces FDA Clearance of New InSet(TM) Stemless Humeral Implant
Shoulder Innovations Announces FDA Clearance of New InSet(TM) Stemless Humeral Implant
HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
HSMN NewsFeed - 28 Feb 2022
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
HSMN NewsFeed - 28 Feb 2022
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
HSMN NewsFeed - 17 Feb 2022
AiM Medical Robotics Appoints Dr. Gregory Cole as Chief Technology Officer
AiM Medical Robotics Appoints Dr. Gregory Cole as Chief Technology Officer
HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
HSMN NewsFeed - 28 Oct 2021
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
HSMN NewsFeed - 27 Oct 2021
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
HSMN NewsFeed - 15 Oct 2021
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
HSMN NewsFeed - 1 Sep 2021
Tyber Medical Receives Largest FDA 510(k) Clearance For Expanded Line Of Anatomical Plating Systems
Tyber Medical Receives Largest FDA 510(k) Clearance For Expanded Line Of Anatomical Plating Systems
HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
HSMN NewsFeed - 23 Aug 2021
Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
HSMN NewsFeed - 20 Aug 2021
Cardiac Dimensions(R) Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial
Cardiac Dimensions(R) Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial
HSMN NewsFeed - 19 Aug 2021
Bunion Patients Have a Walking Recovery and an Invisible Incision With the miniBunion 3D(TM) System
Bunion Patients Have a Walking Recovery and an Invisible Incision With the miniBunion 3D(TM) System
HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
HSMN NewsFeed - 5 Aug 2021
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
HSMN NewsFeed - 2 Aug 2021
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO
HSMN NewsFeed - 30 Jul 2021
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
HSMN NewsFeed - 21 Jul 2021
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
HSMN NewsFeed - 14 Jul 2021
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
HSMN NewsFeed - 16 Jun 2021
Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer
Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer
HSMN NewsFeed - 9 Jun 2021
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
HSMN NewsFeed - 3 May 2021
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
HSMN NewsFeed - 20 Apr 2021
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
HSMN NewsFeed - 31 Mar 2021
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
HSMN NewsFeed - 19 Mar 2021
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
HSMN NewsFeed - 25 Jan 2021
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
HSMN NewsFeed - 19 Jan 2021
Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
HSMN NewsFeed - 12 Jan 2021
Conventus-Flower Announces New Executive Vice President of Marketing and R&D
Conventus-Flower Announces New Executive Vice President of Marketing and R&D
HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
HSMN NewsFeed - 11 Jan 2021
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
HSMN NewsFeed - 22 Dec 2020
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
HSMN NewsFeed - 14 Dec 2020
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
HSMN NewsFeed - 19 Nov 2020
LimaCorporate Announces FDA Approval for an IDE Study on SMR Stemless Reverse Shoulder System
LimaCorporate Announces FDA Approval for an IDE Study on SMR Stemless Reverse Shoulder System
HSMN NewsFeed - 18 Nov 2020
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 9 Nov 2020
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
HSMN NewsFeed - 22 Oct 2020
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
HSMN NewsFeed - 19 Oct 2020
Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
HSMN NewsFeed - 12 Oct 2020
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
HSMN NewsFeed - 8 Oct 2020
First Patients Treated with Galaxy Medical's Centauri(TM) Pulsed Electric Field Cardiac Ablation System
First Patients Treated with Galaxy Medical's Centauri(TM) Pulsed Electric Field Cardiac Ablation System
HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
HSMN NewsFeed - 22 Sep 2020
NanoVibronix UroShield(R) Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
NanoVibronix UroShield(R) Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
HSMN NewsFeed - 18 Sep 2020
Orfadin(R) (nitisinone) receives positive opinion from CHMP for treatment of AKU
Orfadin(R) (nitisinone) receives positive opinion from CHMP for treatment of AKU
HSMN NewsFeed - 8 Sep 2020
Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
HSMN NewsFeed - 4 Sep 2020
AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
HSMN NewsFeed - 20 Jul 2020
Exero Medical Completes First In-Human Implant of Wireless Anastomotic Leak Sensor at Rabin Medical Center
Exero Medical Completes First In-Human Implant of Wireless Anastomotic Leak Sensor at Rabin Medical Center
HSMN NewsFeed - 14 Jul 2020
CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation
CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation
HSMN NewsFeed - 6 Jul 2020
NuVera Announces Successful First-in-Human Use of NuVision(TM) ICE Catheter
NuVera Announces Successful First-in-Human Use of NuVision(TM) ICE Catheter
HSMN NewsFeed - 1 Jun 2020
Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense(TM) Noninvasive Thermal Sensor
Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense(TM) Noninvasive Thermal Sensor
HSMN NewsFeed - 26 May 2020
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
HSMN NewsFeed - 7 May 2020
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 27 Apr 2020
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
HSMN NewsFeed - 13 Apr 2020
U.S. FDA Grants CytoSorb(R) Emergency Use Authorization for Use in Patients with COVID-19 Infection
U.S. FDA Grants CytoSorb(R) Emergency Use Authorization for Use in Patients with COVID-19 Infection
HSMN NewsFeed - 9 Apr 2020
CrossRoads(R) Extremity Systems Unveils miniBunion(TM) Minimally-Invasive Bunion Correction Technique
CrossRoads(R) Extremity Systems Unveils miniBunion(TM) Minimally-Invasive Bunion Correction Technique
HSMN NewsFeed - 20 Mar 2020
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant
HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 7 Feb 2020
Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition
Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition
HSMN NewsFeed - 30 Jan 2020
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
HSMN NewsFeed - 29 Jan 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
HSMN NewsFeed - 28 Jan 2020
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
HSMN NewsFeed - 23 Jan 2020
Bardy Diagnostics(TM) Announces Commercial Launch of the 14-Day Carnation Ambulatory Monitor (CAM) Patch
Bardy Diagnostics(TM) Announces Commercial Launch of the 14-Day Carnation Ambulatory Monitor (CAM) Patch
HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
HSMN NewsFeed - 13 Jan 2020
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
HSMN NewsFeed - 8 Jan 2020
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
HSMN NewsFeed - 6 Jan 2020
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
HSMN NewsFeed - 18 Dec 2019
Conventus Orthopaedics Acquires Novel Intramedullary Technology from IntraFuse
Conventus Orthopaedics Acquires Novel Intramedullary Technology from IntraFuse
HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
HSMN NewsFeed - 26 Nov 2019
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
HSMN NewsFeed - 25 Nov 2019
CurveBeam Introduces Bilateral Weight Bearing CT Imaging of the Hip at RSNA 2019
CurveBeam Introduces Bilateral Weight Bearing CT Imaging of the Hip at RSNA 2019
HSMN NewsFeed - 11 Nov 2019
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
HSMN NewsFeed - 4 Nov 2019
AMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
AMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
HSMN NewsFeed - 29 Oct 2019
Gordian Surgical Raises $3 Million for Commercialization of Its Laparoscopic Closure System
Gordian Surgical Raises $3 Million for Commercialization of Its Laparoscopic Closure System
HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
HSMN NewsFeed - 14 Oct 2019
OssDsign Receives US FDA Clearance for Cranial PSI Accessories - Strengthening Business Position in the US
OssDsign Receives US FDA Clearance for Cranial PSI Accessories - Strengthening Business Position in the US
HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
HSMN NewsFeed - 16 Sep 2019
Zimmer Biomet Receives FDA Clearance of JuggerStitch(TM) Meniscal Repair Device
Zimmer Biomet Receives FDA Clearance of JuggerStitch(TM) Meniscal Repair Device
HSMN NewsFeed - 12 Sep 2019
Camber Spine Announces Nationwide Launch Of SPIRA-O Open Matrix OLIF at NASS 2019
Camber Spine Announces Nationwide Launch Of SPIRA-O Open Matrix OLIF at NASS 2019
HSMN NewsFeed - 9 Sep 2019
Zimmer Biomet Commences Commercial Release of Persona(R) Revision Knee System
Zimmer Biomet Commences Commercial Release of Persona(R) Revision Knee System
HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
HSMN NewsFeed - 16 Aug 2019
Zimmer Biomet's Innovative Treatment for Young Patients with Scoliosis Receives FDA Approval
Zimmer Biomet's Innovative Treatment for Young Patients with Scoliosis Receives FDA Approval
HSMN NewsFeed - 12 Aug 2019
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
HSMN NewsFeed - 1 Jul 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 27 Jun 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
HSMN NewsFeed - 17 Jun 2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
HSMN NewsFeed - 4 Jun 2019
Patrick Coyle Appointed Vice President and Chief Financial Officer of Eisai Inc.
Patrick Coyle Appointed Vice President and Chief Financial Officer of Eisai Inc.
HSMN NewsFeed - 14 May 2019
CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
Additional items found! 500
Members Archive contains
500 additional stories matching:
XTR
(Password required)
XTR
(Password required)